Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (483) 483
Book Review (54) 54
Conference Proceeding (33) 33
Publication (24) 24
Book / eBook (10) 10
Newspaper Article (5) 5
Newsletter (4) 4
Web Resource (3) 3
Book Chapter (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (313) 313
humans (279) 279
oncology (257) 257
male (122) 122
cancer (116) 116
female (116) 116
chemotherapy (95) 95
animals (85) 85
middle aged (77) 77
aged (71) 71
mice (57) 57
antineoplastic agents - therapeutic use (54) 54
adult (51) 51
neoplasms - drug therapy (49) 49
abridged index medicus (48) 48
care and treatment (46) 46
treatment outcome (46) 46
tumors (46) 46
research (45) 45
prostate cancer (44) 44
therapy (43) 43
quality of life (42) 42
prostatic neoplasms - drug therapy (38) 38
antineoplastic combined chemotherapy protocols - therapeutic use (37) 37
breast neoplasms - drug therapy (37) 37
prognosis (34) 34
clinical trials (33) 33
randomized controlled trials as topic (33) 33
aged, 80 and over (31) 31
breast cancer (31) 31
survival (31) 31
antineoplastic agents - adverse effects (29) 29
survival analysis (28) 28
breast-cancer (27) 27
medicine, general & internal (27) 27
time factors (27) 27
analysis (26) 26
clinical-trials (26) 26
drug therapy (26) 26
health aspects (26) 26
disease-free survival (25) 25
quality-of-life (25) 25
hematology, oncology and palliative medicine (24) 24
neoplasms - therapy (24) 24
carcinoma (23) 23
cell lung-cancer (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
cancer therapies (22) 22
neoplasm metastasis (22) 22
risk factors (22) 22
urology & nephrology (22) 22
drug administration schedule (21) 21
metastasis (21) 21
neoplasms - pathology (21) 21
antineoplastic agents - administration & dosage (20) 20
mitoxantrone plus prednisone (20) 20
phase-iii trial (20) 20
prostatic neoplasms - pathology (20) 20
radiotherapy (20) 20
drug resistance, neoplasm (19) 19
retrospective studies (19) 19
taxoids - administration & dosage (19) 19
breast neoplasms - pathology (18) 18
combined modality therapy (18) 18
solid tumors (18) 18
survival rate (18) 18
cell line, tumor (17) 17
docetaxel (17) 17
prostate-specific antigen - blood (17) 17
adjuvant chemotherapy (16) 16
neoplasms - metabolism (16) 16
physiological aspects (16) 16
proportional hazards models (16) 16
antineoplastic agents - pharmacology (15) 15
cognition disorders - chemically induced (15) 15
doxorubicin (15) 15
drug resistance (15) 15
hydrogen-ion concentration (15) 15
medicine & public health (15) 15
men (15) 15
neuropsychological tests (15) 15
oncology, experimental (15) 15
research design (15) 15
usage (15) 15
cell survival - drug effects (14) 14
clinical trials as topic (14) 14
double-blind (14) 14
fatigue (14) 14
lung-cancer (14) 14
methotrexate (14) 14
mice, nude (14) 14
surveys and questionnaires (14) 14
urinary bladder neoplasms - drug therapy (14) 14
xenograft model antitumor assays (14) 14
antineoplastic agents (13) 13
cancer research (13) 13
chemotherapy, adjuvant (13) 13
clinical trials, phase iii as topic (13) 13
medical oncology (13) 13
patients (13) 13
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
OISE - Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. The basic science of oncology
by Tannock, Ian
2013, 5th ed., ISBN 0071745203
Neoplasms
Web Resource
Details down arrow
2. The basic science of oncology
by Tannock, Ian
2013, 5th ed., ISBN 0071745203
Neoplasms
Web Resource
Details down arrow
3. The Basic science of oncology
by Hill, Richard P., 1942 and Tannock, Ian
1987, ISBN 9780080323886, viii, 398
Oncology | Neoplasms | Cancer
Book
Details down arrow
4. The Basic science of oncology
by Hill, Richard P., 1942 and Tannock, Ian
1992, 2nd ed., ISBN 0071054073, ix, 420
Oncology | Neoplasms | Cancer
Book
Details down arrow
5. Full Text Limits to Personalized Cancer Medicine
by Tannock, Ian F and Hickman, John A
The New England Journal of Medicine, ISSN 0028-4793, 09/2016, Volume 375, Issue 13, pp. 1289 - 1294
The widespread dissemination of the idea of personalized oncology has spread faster than the underlying science. The authors argue that the principles of... 
TRIAL | SURVIVAL | MEDICINE, GENERAL & INTERNAL | MULTICENTER | INHIBITION | ADENOCARCINOMA | METASTATIC BREAST-CANCER | INTRATUMOR HETEROGENEITY | BRANCHED EVOLUTION | PRECISION MEDICINE | VEMURAFENIB | Drug Costs | Financing, Government | Drug Resistance, Neoplasm - genetics | Neoplasms - therapy | Neoplasms - genetics | Humans | Precision Medicine - economics | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - economics | Neoplasms - drug therapy | Antimitotic agents | Antineoplastic agents | Dosage and administration | Oncology | Precision medicine | Cancer therapies | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
by Zimmermann, Camilla, Dr and Swami, Nadia, BSc and Krzyzanowska, Monika, MD and Hannon, Breffni, MBChB and Leighl, Natasha, MD and Oza, Amit, Prof and Moore, Malcolm, Prof and Rydall, Anne, MSc and Rodin, Gary, Prof and Tannock, Ian, Prof and Donner, Allan, Prof and Lo, Christopher, PhD
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9930, pp. 1721 - 1730
Summary Background Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early... 
Internal Medicine | VALIDATION | MEDICINE, GENERAL & INTERNAL | PEOPLE | QUALITY-OF-LIFE | ONCOLOGY | INTEGRATION | Single-Blind Method | Follow-Up Studies | Humans | Middle Aged | Male | Psychometrics | Treatment Outcome | Neoplasms - psychology | Outpatient Clinics, Hospital - organization & administration | Palliative Care - organization & administration | Patient Satisfaction | Palliative Care - psychology | Neoplasms - therapy | Early Medical Intervention - organization & administration | Quality of Life | Female | Aged | Ontario | Cancer patients | Care and treatment | Usage | Analysis | Palliative treatment | Research | Quality of life | Intervention | Clinics | Lung cancer | Oncology | Patients | Studies | Hospitals | Consent | Health care networks | Medical prognosis | Hospice care | Palliative care | Patient satisfaction | Chronic illnesses | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. The basic science of oncology
by Tannock, Ian
2005, 4th ed., ISBN 9780071387743, xi, 555
Neoplasms
Book
Details down arrow
8. Full Text Improving Treatment for Advanced Prostate Cancer
by Tannock, Ian F
The New England Journal of Medicine, ISSN 0028-4793, 07/2019, Volume 381, Issue 2, pp. 176 - 177
For about 75 years, the primary treatment for men with metastatic prostate cancer has been with androgen-deprivation therapy, by either surgical or medical... 
MEDICINE, GENERAL & INTERNAL | ABIRATERONE | Treatment outcome | Drug therapy | Prostate cancer | Analysis | Prostate-specific antigen | Palliation | Metastasis | Cancer therapies | Metastases | Serum levels | Androgens | Chemotherapy | Flutamide | Castration | Pharmaceutical industry | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
by Lee, Carol M and Tannock, Ian F
BMC Cancer, ISSN 1471-2407, 06/2010, Volume 10, Issue 1, pp. 255 - 255
Background: Poor distribution of some anticancer drugs in solid tumors may limit their anti-tumor activity. Methods: Here we used immunohistochemistry to... 
ADJUVANT CHEMOTHERAPY | TARGETED THERAPY | GROWTH-FACTOR RECEPTOR | HUMAN-COLON | PHARMACOKINETICS | ONCOLOGY | DRUG-DELIVERY | COLORECTAL-CANCER | BINDING | HER2-POSITIVE BREAST-CANCER | CELL CARCINOMA | Immunohistochemistry | Neoplasm Transplantation | Receptor, Epidermal Growth Factor - genetics | Injections, Intravenous | Receptor, ErbB-2 - genetics | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Receptor, ErbB-2 - metabolism | Half-Life | Antineoplastic Agents - administration & dosage | Breast Neoplasms - metabolism | Cell Hypoxia | Tissue Distribution | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Transfection | Female | Antineoplastic Agents - pharmacokinetics | Cetuximab | Injections, Intraperitoneal | Antibodies, Monoclonal - pharmacokinetics | Breast Neoplasms - blood supply | Animals | Breast Neoplasms - genetics | Antibodies, Monoclonal - administration & dosage | Mice, Nude | Cell Line, Tumor | Carcinoma, Squamous Cell - blood supply | Mice | Trastuzumab | Antimitotic agents | Monoclonal antibodies | Antineoplastic agents | Drug therapy | Health aspects | Tumors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. The basic science of oncology
by Hill, Richard P., 1942 and Tannock, Ian
1998, 3rd ed., ISBN 0071054847, xii, 539
Oncology | Neoplasms | Cancer
Book
Details down arrow
11. Full Text When are positive clinical trials in oncology truly positive?
by Ocana, Alberto and Tannock, Ian F
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2011, Volume 103, Issue 1, pp. 16 - 20
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Can modelling of PSA dynamics accelerate drug development for prostate cancer?
by Tannock, Ian F
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 16 - 18
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MITOXANTRONE PLUS PREDNISONE | SOCIETY | Prostate-Specific Antigen | Prostatic Neoplasms | Male | Humans | Drug therapy | Prostate cancer | Models | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Resistance through repopulation
by Tannock, Ian F
Nature, ISSN 0028-0836, 01/2015, Volume 517, Issue 7533, pp. 152 - 153
The fall in white-blood-cell count stimulates the production of haematological growth factors, which signal slowly proliferating bone-marrow stem cells to... 
Chemotherapy | Prostaglandins E | Oncology, Experimental | Physiological aspects | Research | Drug resistance | Drug therapy | Bladder cancer | Health aspects | Cancer | Stem cells | Bladder | Mathematical models | Cancer therapies | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text The five Rs of chemotherapy
by Tannock, Ian F
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 703 - 705
Hematology, Oncology and Palliative Medicine | CELLS | THERAPY | ONCOLOGY | REPOPULATION | DRUG-RESISTANCE | AUTOPHAGY | CANCER | Drug Resistance, Neoplasm - genetics | Neoplastic Stem Cells - drug effects | Humans | Radiation Tolerance - genetics | Dose Fractionation | Neoplasms - radiotherapy | Neoplasms - pathology | Drug Therapy - trends | Neoplasms - drug therapy | Neoplastic Stem Cells - radiation effects | Chemotherapy | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib
by Grantab, Rama H and Tannock, Ian F
BMC Cancer, ISSN 1471-2407, 06/2012, Volume 12, Issue 1, pp. 214 - 214
Background: Limited penetration of anticancer drugs in solid tumours is a probable cause of drug resistance. Our previous results indicate that drug... 
LUNG-CANCER | TRANSPORT | SOLID TUMORS | ONCOLOGY | PROTEASOME INHIBITOR PS-341 | RESISTANCE | GROWTH-FACTOR | KAPPA-B | HYPERTENSION | CHEMOTHERAPY | XENOGRAFTS | Boronic Acids - toxicity | Humans | Pyrazines - administration & dosage | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - administration & dosage | Antineoplastic Agents - toxicity | Tissue Distribution | Pyrazines - toxicity | Extracellular Fluid | Antineoplastic Agents - pharmacology | Boronic Acids - administration & dosage | Cell Culture Techniques | Tumor Microenvironment - drug effects | Bortezomib | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Neoplasms - pathology | Pyrazines - pharmacology | Boronic Acids - pharmacology | Antimitotic agents | Research | Antineoplastic agents | Analysis | Cancer cells | Chemotherapy | Anthracyclines | Colon cancer | Probable cause | Drug therapy | Drug resistance | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
by Tannock, Ian F, Prof and Fizazi, Karim, Prof and Ivanov, Sergey, MD and Karlsson, Camilla Thellenberg, MD and Fléchon, Aude, MD and Skoneczna, Iwona, MD and Orlandi, Francisco, MD and Gravis, Gwenaelle, MD and Matveev, Vsevolod, MD and Bavbek, Sevil, Prof and Gil, Thierry, MD and Viana, Luciano, MD and Arén, Osvaldo, MD and Karyakin, Oleg, Prof and Elliott, Tony, PhD and Birtle, Alison, MD and Magherini, Emmanuelle, MD and Hatteville, Laurence, MSc and Petrylak, Daniel, Prof and Tombal, Bertrand, Prof and Rosenthal, Mark, Prof and VENICE Investigators and VENICE investigators
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 760 - 768
Summary Background Docetaxel plus prednisone is standard first-line chemotherapy for men with metastatic castrate-resistant prostate cancer. Aflibercept is a... 
Hematology, Oncology and Palliative Medicine | MITOXANTRONE PLUS PREDNISONE | THERAPY | SOLID TUMORS | ONCOLOGY | BEVACIZUMAB | CLINICAL-TRIALS | END-POINTS | QUALITY-OF-LIFE | INCREASED SURVIVAL | III TRIAL | CHEMOTHERAPY | South America | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | North America | Time Factors | Aged, 80 and over | Adult | Prostatic Neoplasms - drug therapy | Recombinant Fusion Proteins - administration & dosage | Prednisone - administration & dosage | Double-Blind Method | Drug Administration Schedule | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms - mortality | Orchiectomy | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Taxoids - administration & dosage | Prostatic Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Androgen Antagonists - therapeutic use | Aged | Care and treatment | Chemotherapy | Corticosteroids | Docetaxel | Clinical trials | Prednisone | Metastasis | Prostate cancer | Vascular endothelial growth factor | Cancer | Protein binding | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Delivering affordable cancer care in high-income countries
by Sullivan, Richard, Prof and Peppercorn, Jeffrey, Prof and Sikora, Karol, Prof and Zalcberg, John, Prof and Meropol, Neal J, Prof and Amir, Eitan, MBChB and Khayat, David, MD and Boyle, Peter, Prof and Autier, Philippe, PhD and Tannock, Ian F, Prof and Fojo, Tito, MD and Siderov, Jim, MClinPharm and Williamson, Steve, MRPharmS and Camporesi, Silvia, PhD and McVie, J Gordon, Prof and Purushotham, Arnie D, Prof and Naredi, Peter, Prof and Eggermont, Alexander, Prof and Brennan, Murray F, Prof and Steinberg, Michael L, Prof and De Ridder, Mark, Prof and McCloskey, Susan A, MD and Verellen, Dirk, Prof and Roberts, Terence, MD and Storme, Guy, Prof and Hicks, Rodney J, Prof and Ell, Peter J, Prof and Hirsch, Bradford R, MD and Carbone, David P, Prof and Schulman, Kevin A, Prof and Catchpole, Paul, PhD and Taylor, David, Prof and Geissler, Jan, PhD and Brinker, Nancy G and Meltzer, David, Prof and Kerr, David, Prof and Aapro, Matti, Prof and Medicinska fakulteten and Kirurgi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 10, pp. 933 - 980
Summary The burden of cancer is growing, and the disease is becoming a major economic expenditure for all developed countries. In 2008, the worldwide cost of... 
Hematology, Oncology and Palliative Medicine | CELL LUNG-CANCER | COST-EFFECTIVENESS ANALYSIS | HEALTH-TECHNOLOGY-ASSESSMENT | ERLOTINIB PLUS GEMCITABINE | STAGE BREAST-CANCER | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | RANDOMIZED PHASE-III | CLINICAL-TRIALS | BODY RADIATION-THERAPY | ADVANCED PANCREATIC-CANCER | Health Expenditures - legislation & jurisprudence | Neoplasms - economics | Delivery of Health Care, Integrated - legislation & jurisprudence | Health Care Costs - legislation & jurisprudence | United States | Europe | Humans | Health Services Accessibility - legislation & jurisprudence | Neoplasms - diagnosis | Models, Economic | Health Care Reform - economics | Health Services Misuse - economics | Health Services Research | Socioeconomic Factors | Cost Savings | Health Services Accessibility - economics | Neoplasms - therapy | Healthcare Disparities - economics | Delivery of Health Care, Integrated - economics | Cost-Benefit Analysis | Australia | Health Policy - economics | Insurance, Health - economics | Drugs | Medical colleges | Care and treatment | Oncology, Experimental | Leukemia | Radiation | Research | Cancer | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18.